Affinity Asset Advisors »

Teva Pharmaceutical Industries shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $32M 3.1M 10.20
2023-06-30 $12M 1.6M 7.53

More positions owned by Affinity Asset Advisors

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Apogee Therapeutics (APGE)
Establishment Labs Holdings Ord (ESTA)
Cymabay Therapeutics
Immunovant (IMVT)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Madrigal Pharmaceuticals (MDGL)
Xenon Pharmaceuticals (XENE)
Alkermes SHS Call Option (ALKS)
Kura Oncology (KURA)
Astria Therapeutics (ATXS)
Morphic Hldg (MORF)

View all positions for Affinity Asset Advisors

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Harel Insurance Investments & Financial Services
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Meitav Dash Investments

View all funds holding Teva Pharmaceutical Industries